Haemonetics Corporation (HAE)

Revenue by Geography

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 28, 2026	Mar 29, 2025	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022	Apr 3, 2021	Mar 28, 2020	Mar 30, 2019	Mar 31, 2018	Apr 1, 2017	Apr 2, 2016	Mar 28, 2015	Mar 29, 2014	Mar 30, 2013
United States Revenue	982.18M	1.01B
United States Revenue Growth	-2.84%	4.22%
Japan Revenue	68.20M	62.41M
Japan Revenue Growth	9.28%	7.44%
Europe Revenue	185.02M	175.66M
Europe Revenue Growth	5.33%	9.69%
Asia Revenue	87.21M	92.31M
Asia Revenue Growth	-5.52%	-14.16%
Other Geographic Revenue	11.42M	19.54M
Other Geographic Revenue Growth	-41.55%	47.09%
Revenue (Other)	3.00K	-6.00K
Revenue (Total)	1.33B	1.36B
Revenue (Total) Growth	-1.97%	3.95%

Revenue Breakdown 2

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 28, 2026	Mar 29, 2025	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022	Apr 3, 2021	Mar 28, 2020	Mar 30, 2019	Mar 31, 2018	Apr 1, 2017	Apr 2, 2016	Mar 28, 2015	Mar 29, 2014	Mar 30, 2013
Plasma Revenue	524.46M	535.43M
Plasma Revenue Growth	-2.05%	-5.99%
Blood Center Revenue	221.27M	261.12M
Blood Center Revenue Growth	-15.26%	-7.80%
Hospital Revenue	588.30M	564.27M
Hospital Revenue Growth	4.26%	23.66%
Revenue (Total)	1.33B	1.36B
Revenue (Total) Growth	-1.97%	3.95%

EBIT

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 28, 2026	Mar 29, 2025	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022	Apr 3, 2021	Mar 28, 2020	Mar 30, 2019	Mar 31, 2018	Apr 1, 2017	Apr 2, 2016	Mar 28, 2015	Mar 29, 2014	Mar 30, 2013
Plasma Segment Operating Income (Post-Q3 2025 Reporting)	184.80M	184.51M
Plasma Segment Operating Income (Post-Q3 2025 Reporting) Growth	0.15%	1.40%
Blood Center Segment Operating Income (Post-Q3 2025 Reporting)	49.98M	52.82M
Blood Center Segment Operating Income (Post-Q3 2025 Reporting) Growth	-5.38%	24.65%
Hospital Segment Operating Income (Post-Q3 2025 Reporting)	103.74M	88.98M
Hospital Segment Operating Income (Post-Q3 2025 Reporting) Growth	16.59%	70.46%
Operating Income (Total)	156.73M	221.82M
Operating Income (Total) Growth	-29.34%	34.53%

Data Source: Fiscal.ai Last updated: May 7, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 14, 2026

Data Sources Report a data error